SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HBOC...Buy in here?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Chuzzlewit who wrote (146)7/16/1998 5:56:00 PM
From: dougjn  Read Replies (1) of 341
 
While the market reaction seems clearly overdone, it makes some sense to me.

I think there is some concern that the beast we know and love was on the verge of possibly becoming something else. Medical management software company almost acquires a drug distribution company??? With much lower growth and margins. Deal is scuttled, apparently (or is it merely being somewhat renegotiated??) after leaks reveal that the Street hates the deal and tanks Hboc's stock.

Makes you wonder what management is up to, no? Does this mean that growth prospects in their core market are drying up?

Is there some other reason for the deal that is not immediately apparent? Are they starting to play mere classic roll up games with lower PE, lower growth and lower margined targets? (The lower PE is fine; the other two aren't -- they lead to inevitable slowdown and likely future crash.)

Thoughts??

Doug
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext